The CHILI consortium envisions to optimize cervical cancer screening in low- and middle-income countries by offering a modified, cost-effective version of the point-of-care ELEVATE tool to test self-sampled samples. This promising device, which has the potential to reduce drastically the cancer burden in developing countries, will be implemented in four countries, namely Cambodia, Ethiopia, Mozambique and Uganda.

Our partners

The CHILI project is a collaboration between one Southeast Asian investigator group, three African research centres and eight European partners. It brings together a multidisciplinary team composed of experts in public health, technology development, clinical/community and social health researchers, health economics, medical instrumentation and project management.

About cervical cancer

Despite being one of the most preventable cancers, in 2020 cervical cancer – caused by the Human Papillomavirus (HPV) – was the fourth most prevalent cancer in women, with close to 85% of the related global burden occurring in low-and middle-income countries.

Do you have a question about the project?

Do you have a question about the project?